ERBB2 and breast cancer: Thus, our data demonstrate that butein inhibition of AKT phosphorylation is related with apoptosis of different breast cancer cells except for butein-resistant and luminal HER2+ HCC-1419, HCC-2218 and SKBR-3 cells.